ReviewDiscover oncology2025
Mendelian randomization analysis of modifiable risk factors for breast cancer.
Review in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrating single-cell transcriptomics and epigenetics in a multi-omics MR framework identifies PARK7 as a causal gene in streptococcal septicemia.Epigenetics & chromatin · 2026Article
- Seipin as a Putative Protective Factor for Breast Cancer: Evidence from Mendelian Randomization Analysis.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review explores the role of Mendelian randomization (MR) in the analysis of modifiable risk factors for breast cancer. Breast cancer is the most common cancer in women, with risk factors including lifestyle, genetic predisposition, and hormonal influences. Mendelian randomization (MR) is a robust epidemiological tool, uses genetic variants to assess causal relationships between exposures and breast cancer risk. Evidence suggests that obesity, particularly in adulthood, is associated with elevated risk, while early obesity may be protective. Alcohol consumption shows a complex relationship, with adverse effects associated with problematic drinking behaviors rather than moderate drinking. Physical activity is associated with reduced breast cancer risk, likely through hormonal and metabolic pathways. Dietary factors, such as higher intake of monounsaturated fatty acids and vitamin E, appear protective, highlighting the importance of dietary choices. Methodological considerations, including pleiotropy and sample size, are crucial to ensure the validity of MR studies. Overall, this synthesis of existing studies demonstrates the importance of Mendelian randomization (MR) in identifying causal links between modifiable risk factors and breast cancer, which is essential for developing targeted prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.